drugset / Trial / NCT02195635
Phase 1, Open-label, Drug-drug Interaction Study With Octreotide Acetate Injection and Telotristat Etiprate in Healthy Subjects
Non-randomizedSingle-groupOpen-labelTreatment
Summary
To evaluate the effect of octreotide acetate injections (200 µg 3 times daily \[tid\]) on the pharmacokinetics (PK) of telotristat ethyl and its metabolite LP-778902 relative to administration of single-dose telotristat etiprate in healthy male and female subjects
Timeline
- Start
- 2014-07
- Primary completion
- 2014-10
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Octreotide | Peptide | 200 ug | Subcutaneous |
| Subject | Telotristat etiprate | Unknown | 500 mg | Oral |
Indications
No indication recorded.